Charmacy Pharmaceutical Co., Ltd. (2289.HK)
HKD 9.0
(0.0%)
HKD 9.0
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 4.4 Billion | 4.17 Billion | 3.79 Billion | 3.99 Billion | 3.49 Billion | 3.93 Billion |
| Cost of Revenue | 4.11 Billion | 3.9 Billion | 3.55 Billion | 3.75 Billion | 3.27 Billion | 3.7 Billion |
| Gross Profit | 292.74 Million | 268.6 Million | 234.11 Million | 237.4 Million | 220.64 Million | 235.12 Million |
| Operating Expenses | 222.18 Million | 116.08 Million | 163.41 Million | 154.94 Million | 138.8 Million | 143.55 Million |
| Selling, General and Administrative Expenses | 170.8 Million | 165.04 Million | 151.55 Million | 143.04 Million | 128.14 Million | 130.18 Million |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | 51.38 Million | -372.28 Thousand | -128.43 Thousand | -37 Thousand | 65.91 Thousand | 219.11 Thousand |
| Cost and Expenses | 4.33 Billion | 4.02 Billion | 3.72 Billion | 3.9 Billion | 3.41 Billion | 3.84 Billion |
| Operating Income | 66.19 Million | 93.48 Million | 74.42 Million | 88.07 Million | 85.19 Million | 99.08 Million |
| Interest Expense | 40.79 Million | 35.07 Million | 41.51 Million | 31.73 Million | 30.42 Million | 31.09 Million |
| Income Tax Expense | 16.07 Million | 31.67 Million | 9.82 Million | 14.18 Million | 14.89 Million | 18.89 Million |
| Earnings before Tax | 67.41 Million | 122.05 Million | 32.98 Million | 54.74 Million | 55.04 Million | 63.65 Million |
| Net Income | 51.34 Million | 90.47 Million | 23.15 Million | 40.55 Million | 40.15 Million | 45.43 Million |
| Earnings Per Share Basic | 0.48 | 0.84 | 0.21 | 0.38 | 0.37 | 0.42 |
| Earnings Per Share Diluted | 0.48 | 0.84 | 0.21 | 0.38 | 0.37 | 0.42 |
| Weighted Average Shares Outstanding | 108 Million | 107.99 Million | 107.99 Million | 108 Million | 107.99 Million | 107.99 Million |
| Weighted Average Shares Outstanding (Diluted) | 108 Million | 107.99 Million | 107.99 Million | 108 Million | 107.99 Million | 107.99 Million |
| Gross Margin | 0.07 | 0.06 | 0.06 | 0.06 | 0.06 | 0.06 |
| EBIT Margin | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 |
| Profit Margin | 0.01 | 0.02 | 0.01 | 0.01 | 0.01 | 0.01 |
| EBITDA | 136.92 Million | 119.18 Million | 107.55 Million | 111.03 Million | 110.14 Million | 113.8 Million |
| Earnings Before Tax Margin | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.03 |
| Breakdown | 2024 Q2 | 2023 Q4 | 2023 FY | 2023 Q2 | 2022 Q4 | 2022 FY |
|---|---|---|---|---|---|---|
| Revenue | 2.34 Billion | 2.13 Billion | 4.4 Billion | 2.26 Billion | 2.28 Billion | 4.17 Billion |
| Cost of Revenue | 2.18 Billion | 1.98 Billion | 4.11 Billion | 2.13 Billion | 2.14 Billion | 3.9 Billion |
| Gross Profit | 164.96 Million | 149.66 Million | 292.74 Million | 138.71 Million | 147.08 Million | 268.6 Million |
| Operating Expenses | 125.62 Million | 117.45 Million | 178.01 Million | 89.14 Million | 35.31 Million | 116.08 Million |
| Selling, General and Administrative Expenses | 87.07 Million | 88.45 Million | - | 82.34 Million | 92.55 Million | - |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | 38.54 Million | 28.99 Million | -65.56 Thousand | - | - | -372.28 Thousand |
| Cost and Expenses | 2.3 Billion | 2.1 Billion | 4.28 Billion | 2.21 Billion | 2.17 Billion | 4.02 Billion |
| Operating Income | 39.34 Million | 32.21 Million | 66.19 Million | 51.75 Million | 48.99 Million | 93.48 Million |
| Interest Expense | - | - | 40.79 Million | - | - | 35.07 Million |
| Income Tax Expense | 12.18 Million | 7.26 Million | 16.07 Million | 8.8 Million | 26.37 Million | 31.67 Million |
| Earnings before Tax | 38.92 Million | 32.26 Million | 67.41 Million | 35.15 Million | 96.2 Million | 122.05 Million |
| Net Income | 26.74 Million | 24.99 Million | 51.34 Million | 26.35 Million | 69.83 Million | 90.47 Million |
| Earnings Per Share Basic | 0.25 | 0.23 | - | 0.24 | 0.65 | - |
| Earnings Per Share Diluted | 0.25 | 0.23 | - | 0.24 | 0.65 | - |
| Weighted Average Shares Outstanding | 107.98 Million | 108 Million | 108 Million | 108 Million | 107.99 Million | 107.99 Million |
| Weighted Average Shares Outstanding (Diluted) | 107.98 Million | 108 Million | 108 Million | 108 Million | 107.99 Million | 107.99 Million |
| Gross Margin | 0.07 | 0.07 | 0.07 | 0.06 | 0.06 | 0.06 |
| EBIT Margin | 0.04 | 0.03 | - | 0.03 | 0.03 | - |
| Profit Margin | 0.01 | 0.01 | 0.01 | 0.01 | 0.03 | 0.02 |
| EBITDA | 83.43 Million | 66.38 Million | - | 61.7 Million | 61.17 Million | - |
| Earnings Before Tax Margin | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 |
LYEL
FORSE
600685
5935
MLB1
ITMZF